[Skip navigation]FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
 
Powered by Google

Anti-Infective Drugs Advisory Committee Meeting (65th Meeting)
October 15-16, 1998
Holiday Inn, Silver Spring , MD

  1. Advisory Committee on Antibiotic Resistance, Dianne Murphy, M.D.

  2. Antibiotic Resistance: Regulatory Issues and the Drug Development Process, Albert T. Sheldon, Jr. Ph. D. 

  3. Bacteremia as an indication - Historical perspective, David Ross, M.D., Ph.D.

  4. Bacteremia as an indication - Regulatory perspective, David Ross, M.D., Ph.D. 

  5. Defining Antibiotic Resistance: Regulatory Perspective, John Alexander, M.D.

  6. Development of Drugs for Resistant Bacteria, Janice Soreth, M.D.  

  7. Problem: Resistance Outpacing Drug Development, Mark J Goldberger MD MPH

  8. Regulatory Perspective, Gary Chikami, M.D.

  9. Resistance is outpacing drug development, Andrea Meyerhoff MD MSc DTMH

 

CDER Presentations Page

What's NewComments or FeedbackSearchMain CDER Page[CDER Navigational Buttons]
CDER Home Page | Search | Comment | What's New